VPValerii I. Podzolkov

Valerii I. Podzolkov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valerii I. Podzolkov has a total of 433 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The relationship between steatosis and liver fibrosis indicators and impaired carbohydrate metabolism in patients with arterial hypertension

    by A. E. Pokrovskaya, V. I. Podzolkov, D. D. Vanina, V. S. Ivanova, K. E. Krylova, A. V. Podzolkov, I. V. Bacharev, А. Е. Покровская, В. И. Подзолков, Д. Д. Ванина, et al.

    Non-alcoholic fatty liver disease is one of the most common chronic liver diseases that has been proven to increase the risk of cardiovascular disease. The aim of the study: to study the characteristics of steatosis and liver fibrosis, as well as to analyze the body composition in patients with and without carbohydrate metabolism disorders and arterial hypertension (AH). Materials and methods . The study included 100 patients (31 men and 69 women) with AH aged 25 to 80 years with and without carbohydrate metabolism disorders. In addition to standard studies, all patients underwent determination of parameters of fatty hepatosis and liver fibrosis by transient elastometry (TE), determination of the compositional composition of the body. Liver steatosis was diagnosed according to the ultrasound attenuation parameter (UAP) of more than 244 dB/m, liver fibrosis was diagnosed according to the liver stiffness index Fs of more than 7.3 kPa. Results . The patients were divided into 3 groups: without carbohydrate metabolism disorders (50 people), with impaired glucose tolerance (IGT) (18 people), with type 2 diabetes mellitus (DM) (32 patients). The UAP value in patients with IGT significantly exceeded the value in patients without carbohydrate metabolism disorders. The Fs values in the groups with carbohydrate metabolism disorders were comparable, significantly exceeding the values in patients without carbohydrate metabolism disorders. In the group of patients with type 2 diabetes mellitus with non-target HbA1c, liver fibrosis was diagnosed in all examined. A direct correlation was found between the HbA1c level and the Fs indicator. Using linear regression analysis, it was found that an increase in HbA1c by 1% is associated with an increase in liver stiffness by 0.78 kPA. Conclusion . In patients with AH and IGT, the indicators of steatosis and liver stiffness were higher than in patients without carbohydrate metabolism disorders. The level of HbA1c is not only an indicator of carbohydrate metabolism, but also has predictive significance in relation to the development of liver fibrosis. Our study showed the need for a comprehensive examination of patients with carbohydrate metabolism disorders, including transient elastometry, for the timely diagnosis of steatosis and liver fibrosis.

  • Open Access

    The role of non-invasive markers of hepatic steatosis in detecting epicardial obesity

    by A. E. Bragina, Yu. N. Rodionova, A. V. Podzolkov, D. V. Akvitskaya, S. A. Abduganiev, Y. S. Pahomova, A. E. Habarov, D. M. Oganesyan, V. I. Podzolkov, А. Е. Брагина, et al.

    Aim . To evaluate the diagnostic value of various non-invasive methods for assessing hepatic steatosis as potential markers of epicardial obesity (EO) in individuals without cardiovascular disease. Material and methods . This cross-sectional study included 303 patients without cardiovascular diseases with a median age of 55 [40;65] years. Epicardial adipose tissue (EAT) thickness was assessed by echocardiography, and EO was determined according to age-specific threshold values. Hepatic steatosis was verified using liver transient elastography with measurement of the controlled attenuation coefficient (AC) and hepatorenal index (HRI). AC >0.67 dB/cm/MHz was used as the criterion for hepatic steatosis. The cutoff value for HRI was >1.49. In addition, validated non-invasive indices, including the Fatty Liver Index (FLI) and Hepatic Steatosis Index (HSI), were calculated. FLI >60 and HSI >36 was considered diagnostic criteria for hepatic steatosis according to the original formulas. Results . Sex distribution in the study cohort was balanced (49.8% men and 50.2% women). The prevalence of arterial hypertension was 66.3%, dyslipidemia 46.8%, and abdominal obesity 50.4%. EO was detected in 68% of patients. The prevalence of hepatic steatosis assessed by ultrasonography with AC measurement was 41.3%, while HRI-based steatosis was detected in 45% of patients. According to calculated indices, hepatic steatosis was identified in 50.1% of patients using HSI and in 32.3% using FLI. Statistically significant correlations were observed between EAT thickness and hepatic steatosis markers (HSI, FLI, HRI, and AC) (ρ =0.401, ρ =0.507, ρ =0.545, and ρ =0.622, respectively). AC demonstrated the highest diagnostic performance for EO detection (AUC=0.715; 95% CI: 0.575-0.855; p=0.002). Similar results were obtained for FLI (AUC=0.722; 95% CI: 0.598-0.847; p=0.003). Pairwise comparisons revealed statistically significant differences between AC and HSI (p=0.044), as well as between HSI and FLI (p=0.007). Statistically significant differences between the ROC curves (p=0.0417) were confirmed. ROC analysis was additionally performed to determine cutoff values of AC and FLI for EO detection. The optimal AC cutoff value was 0.65 dB/cm/MHz (specificity 70.91%, sensitivity 88%), whereas the optimal FLI cutoff value was 29 (specificity 68.97%, sensitivity 75.44%). Conclusion . The identified associations between hepatic steatosis markers (FLI, HSI, HRI, and AC) and EO are consistent with the concept of a “metabolic dysfunction cluster”, according to which hepatic steatosis may reflect the severity of metabolic disturbances and serve as a marker of cardiovascular risk.

  • Open Access

    NR2-antibodies and cognitive impairment in patients with controlled hypertension

    by V. I. Podzolkov, T. A. Safronova, S. E. Mukhanova, T. S. Vargina, N. A. Dorokhov, В. И. Подзолков, Т. А. Сафронова, С. Э. Муханова, Т. С. Варгина, Н. А. Дорохов

    Aim . To investigate the relationship between cognitive impairment (CI) and serum NR2 antibody (NR2-AB) levels in patients with controlled hypertension (HTN) of stage I-II. Material and methods. A single-centre study included 105 patients (75 with essential HTN and 30 controls) aged 40–70 years. Serum NR2-AB levels were measured by enzyme-linked immunosorbent assay (ELISA), with a threshold of 1.8 ng/mL. Cognitive status was assessed using the Montreal Cognitive Assessment (MoCA): normal ≥26 points, CI ≤25 points. All patients with HTN received combination antihypertensive therapy and had achieved target blood pressure levels at inclusion. Results . NR2-AB levels were significantly higher in HTN patients (2.93 [1.46; 4.13] ng/mL) than in controls (1.35 [1.02; 2.09] ng/mL; p=0.001). CI was detected 8 times more frequently in HTN patients compared with controls (52% vs 6.7%). A negative correlation was observed between NR2-AB levels and MoCA scores (r= 0.2; p=0.048). Furthermore, a significant association between the marker and the presence of cognitive impairment was found in the univariate regression analysis (odds ratio=1.21; 95% confidence interval: 1.027-1.42; p=0.022), suggesting that this neuronal injury marker is linked to cognitive decline. ROC analysis revealed that an NR2-AB cutoff of 1.73 ng/mL had discriminative capacity for CI (sensitivity 71%, specificity 50%). In the multivariable logistic regression analysis, age, body mass index, and the presence of HTN were significantly associated with CI; the association with NR2-AB levels was not statistically significant (p=0.143). Conclusion . In patients with controlled stage I-II HTN, serum NR2AB levels are significantly elevated even after achieving target blood pressure. Age, body mass index, and HTN were significantly associated with CI.

  • Open Access

    The prognostic value of interleukin-6 in the assessment of arrhythmia recurrence in patients with hypertension and paroxysmal atrial fibrillation

    by Aida I. Tarzimanova, Тарзиманова Аида Ильгизовна, Alena Yu. Isaeva, Исаева Алена Юрьевна, Esmira Sh. Samedova, Самедова Эсмира Шахбала Кызы, Valery I. Podzolkov, Подзолков Валерий Иванович

    Aim. To study the prognostic value of interleukin-6 (IL-6) in assessing the risk of arrhythmia recurrence in patients with arterial hypertension (AH) and paroxysmal atrial fibrillation (AF). Materials and methods. 95 patients with AH and paroxysmal AF were included in the study. The prospective follow-up of the patients was 6 months, and the end point of the study was a reported recurrence of AF. Depending on the end point of the study, the patients were divided into 2 groups: group 1 included 32 patients who had a recurrence of AF within 6 months; group 2 consisted of 63 patients without recurrence of arrhythmia. Results. The average concentration of IL-6 in blood plasma at the inclusion visit was significantly higher in patients of group 1 than in patients of group 2 (p0.05). There was a significant increase in the Cardio-Ankle Vascular Index (CAVI index) in patients with AF relapses than in patients without AF relapses – 8.9 [8.6; 9.1] and 7.7 [7.5; 8.3] (p0.05). We found a moderate direct correlation between the value of the CAVI index and the plasma concentration of IL-6 (r=0.6; p=0.024). In patients with AH and paroxysmal AF, a statistically significant association with the likelihood of arrhythmia recurrence was shown by such indicators as the level of IL-6 in blood plasma (Odds Ratio 1.42, 95% Confidence Interval – CI 1.18–1.70; p=0.001) and the CAVI index (Odds Ratio 1.31, 95% CI 1.08–1.58; p=0.005). Conclusion. An increase in the level of IL-6 in blood plasma of more than 4.0 pg/ml with a sensitivity of 70% and specificity of 72% indicates a high risk of AF recurrence in patients with AH and paroxysmal AF (Area Under the Curve – AUC 0.76), increases the risk of recurrence of arrhythmia by 1.42 times (95% CI 1.18–1.70; p=0.001).

  • Open Access

    Common Carotid Artery Extra-Media Thickness as a Marker of Perivascular Obesity and Cardiometabolic Risk in Individuals Without Cardiovascular Disease

    by Anna Bragina, Natalia Druzhinina, Yulia Rodionova, Daria Akvitskaya, Kirill Novikov, Galina Nikiforova, Oksana Avdeenko, Natalia Vlasova, Alina Arzukanyan, Alina Kudravceva, et al.

    Background: Perivascular adipose tissue (PVAT) is increasingly recognized as a pathogenetic contributor to vascular dysfunction. Carotid extra-media thickness (EMT) measured by ultrasound is the simplest, noninvasive and clinically accessible marker of PVAT deposition. However, reference values in young individuals without cardiovascular disease (CVD) are lacking. The aim of this study was to analyze the relationship between carotid EMT and cardiovascular risk factors and to determine a tentative reference value of carotid EMT in individuals without CVD. Methods: This cross-sectional study included 373 patients with a median age of 23 (21; 32) years and without CVD. All patients underwent anthropometric examination, lipid-profile assessment using the CardioChek PA (USA, 2020), and duplex ultrasound of the brachiocephalic arteries with measurement of common carotid artery EMT and intima-media thickness (IMT). A subgroup of apparently healthy individuals without cardiovascular risk factors was selected to define a threshold. EMT above the 90th percentile of this subgroup was regarded as perivascular obesity (PVO). Results: Carotid EMT was significantly associated with age, blood pressure levels, anthropometric and laboratory metabolic markers, glycemia and smoking. On multivariable linear regression, age, obesity and smoking were independently associated with EMT. The 90th percentile threshold in the apparently healthy subgroup (n = 185) was 0.54 mm; EMT ≥ 0.54 mm (PVO) was identified in 24.2% of the sample and was most frequent in individuals aged 41–55 years. On multivariable logistic regression, age and waist circumference were independently associated with the presence of PVO. Conclusions: Carotid EMT, reflecting the severity of PVAT deposition, may be associated with a wide range of cardiometabolic risk factors in individuals without CVD, with a tentative threshold value of 0.54 mm.

  • Acute Effects of Electronic Cigarettes and Heated Tobacco Products on Vascular Stiffness: A Systematic Review and Meta-Analysis

    by Anna Bragina, Natalia Druzhinina, Yulia Rodionova, Ilya Shvedov, Kirill Novikov, Irakli Loriya, Dinara Natkina, Sakinat Abdullayeva, Sergey Muradov, Arina Kozlova, et al.

    Introduction: Cardiovascular diseases remain the leading cause of mortality worldwide. Emerging risk factors, such as electronic cigarettes and Heated Tobacco Products (HTPs), may contribute to vascular damage. This systematic review and meta-analysis aimed to evaluate the association between nicotine-containing electronic cigarettes and HTPs and arterial stiffness. Methods: The study followed PRISMA and Cochrane Collaboration guidelines and was registered in the PROSPERO database (ID: CRD42023446895). PubMed, Scopus, Google Scholar, and eLIBRARY databases from January 1, 2000 to July 30, 2024. Outcomes included Pulse Wave Velocity (PWV), Augmentation Index (AIx), Cardio-Ankle Vascular Index (CAVI), ankle- brachial index (ABI). Results: From 3,705 abstracts, 9 experimental studies (n=190) were included. CAVI and ABI indices were excluded due to limited data. The PWV analysis included 6 studies (n=133) and demonstrated a significant increase following exposure to nicotine-containing products (SMD=1.71 [95% CI: 0.23–3.19, p=0.031]). The AIx analysis included 9 studies (n=190) and also demonstrated a significant increase (SMD=1.05 [95% CI: 0.34–1.76, p=0.008]). Metaregression analyses showed no significant moderating effects of publication year, age, or sex. However, small-study effects and substantial heterogeneity were identified. Discussion: The study’s findings are consistent with previous studies and suggest possible vascular effects of nicotine-containing electronic cigarettes and HTPs. However, limitations require cautious interpretation, and long-term studies are warranted. Conclusion: Evidence suggests a possible acute increase in arterial stiffness following exposure to nicotine-containing electronic cigarettes and HTPs compared with non-smokers or nicotinefree electronic cigarette users, but certainty is limited by high heterogeneity, small samples, and methodological variability.

  • Open Access

    Aldosterone: mechanisms of normal and impaired regulation and the possibility of their correction in arterial hypertension. Consensus of Russian Medical Society on Arterial Hypertension (RSH) experts

    by Novella M. Chikhladze, Чихладзе Новелла Михайловна, Nataliya V. Blinova, Блинова Наталия Владимировна, Olga Iu. Trushina, Трушина Ольга Юрьевна, Valery I. Podzolkov, Подзолков Валерий Иванович, Anna E. Bragina, Брагина Анна Евгеньевна, et al.

    In recent years, studies have been carried out that have expanded the understanding of the role of pathophysiological mechanisms underlying impaired regulation of aldosterone and activation of mineralocorticoid receptors in arterial hypertension. The aim of this consensus is to consider the association between aldosterone dysregulation and the development of cardiovascular complications, as well as to assess the effectivity and safety of novel nonsteroidal mineralocorticoid receptor antagonists, to expand the understanding of their potential in ensuring the prevention of target organ damage and cardiovascular complications in the treatment of patients with hypertension, to analyze the potential of a new class of drugs – aldosterone synthase inhibitors – in ensuring the suppression of genomic and non-genomic effects of aldosterone and their adverse effects in patients with hypertension, to assess the efficacy of drug therapy including nonsteroidal mineralocorticoid receptor antagonists and aldosterone synthase inhibitors in the category of patients at high cardiovascular risk – in hypertension due to primary hyperaldosteronism.


  • Open Access

    Association of metabolic-associated fatty liver disease with arterial stiffness: the role of vitamin D

    by Valery I. Podzolkov, Anna E. Bragina, Yulia N. Rodionova, Maria K. Vasilchenko, Andrey V. Podzolkov, Maria V. Vetluzhskaya, Daria V. Akvitskaya, Klimentiy N. Eltsov, Kirill V. Dementev, Nikita M. Pshenichnikov

    Aim. To investigate the relationship between vitamin D levels, metabolic-associated fatty liver disease (MAFLD), and arterial stiffness. Materials and methods. This study included 303 patients with a median age of 55 [40; 65] years. All participants underwent duplex ultrasonography with assessment of carotid extra-media thickness (EMT), and liver transient elastography with evaluation of the attenuation coefficient (AC) transthoracic echocardiography for measurement of epicardial adipose tissue thickness (EAT). MAFLD was diagnosed based on hepatic steatosis combined with overweight/obesity and at least two metabolic risk factors. Arterial stiffness was evaluated using the cardio-ankle vascular index (CAVI), measured by sphygmomanometry with the VaSera-1000 system FUCUDA DENSHI (Japan). Serum 25-hydroxyvitamin D levels were measured in all participants. Statistical analysis was performed using Statistica 12.0 software. Results. Patients were divided into 4 groups depending on their vitamin D levels. High arterial stiffness was significantly more frequent in patients with severe vitamin D deficiency compared with those with insufficiency and optimal levels (40% vs 19.5%; p=0.006; 40% vs 0%; p0.0001 respectively). The cardio-ankle vascular index (CAVI) was significantly higher in the severe deficiency group compared with the optimal vitamin D group (7.5 [6.5; 8.8] vs 6.6 [5.8; 7.5]; p=0.03). Significant correlations were observed between CAVI and EMT, EAT, AC, and the presence of MAFLD. Vitamin D levels were negatively correlated with AC and MAFLD. ROC analysis demonstrated the highest diagnostic accuracy for detecting increased arterial stiffness using a combined model (AUC vit D + AC + EMT =0.823; p0.0001). Conclusion. Vitamin D is associated with arterial stiffness and ectopic fat deposition, while its combination with AC and EMT provides high diagnostic accuracy for identifying patients at increased cardiometabolic risk.

  • Open Access

    The history of ferroptosis development: from one type of cell death to a new target for antibacterial therapy

    by Valery I. Podzolkov, Подзолков Валерий Иванович, Anna E. Bragina, Брагина Анна Евгеньевна, Liubov A. Ponomareva, Пономарева Любовь Андреевна, Elena N. Popova, Попова Елена Николаевна, Andrey B. Ponomarev, Пономарев Андрей Борисович, et al.

    To date, the role of various types of programmed cell death in the occurrence and progression of infectious diseases has been established. One such type, ferroptosis, which was recently discovered, is characterized by iron-dependent lipid peroxidation and is under investigation in relation to the development of disorders of various organ systems, including infections. Recent researches have revealed previously unknown mechanisms of bacterial damage associated with ferroptotic cell death. For instance, the involvement of ferroptosis in infections caused by multidrug-resistant pathogens such as Pseudomonas aeruginosa, Mycobacterium tuberculosis, Klebsiella pneumonia, and Escherichia coli has been demonstrated. The studied pathogenic mechanisms of these pathogens highlight ferroptosis as a potential therapeutic target for infectious diseases and suggest new possibilities for addressing the challenging problem of antibiotic resistance. In this review, we have summarized the main mechanisms of ferroptosis and highlighted new data on the pathogenic aspects of bacterial damage associated with this process. This information may be useful for developing new therapeutic strategies to combat this condition.

  • Open Access

    Type 2 diabetes mellitus as an independent factor in the severe course of the new coronavirus infection (COVID-19) in obese patients

    by Valery I. Podzolkov, Подзолков Валерий Иванович, Viktor V. Maleev, Малеев Виктор Васильевич, Anna E. Pokrovskaya, Покровская Анна Евгеньевна, Daria D. Vanina, Ванина Дарья Дмитриевна, Lyubov V. Vasil'Eva, Васильева Любовь Викторовна, et al.

    Aim. To study the role of type 2 diabetes mellitus (DM 2) as an independent factor in the severe course of COVID-19 in obese patients. Materials and methods. The data of 1414 obese people hospitalized with COVID-19 at University Clinical Hospital №4 of Sechenov First Moscow State Medical University (Sechenov University), were analyzed. Two groups were formed: group 1 – 256 obese people with DM 2, group 2 – 1158 obese people without DM 2. The severity of COVID-19 was assessed using standard laboratory and instrumental parameters. Death and intensive care unit admission (ICU) were selected as the primary endpoints. Results. Patients with DM 2 had higher markers of inflammation and coagulation. The volume of lung damage according to computed tomography in group 1 exceeded the indicators of group 2 – 40 (27,5; 61,25%) vs 37,5 (25; 45%); p0.05. The frequency of ICU admission and deaths in patients with DM 2 was higher (25 and 16.4%) compared with the indicators of group 2 (6.8 and 4.1%); p0.05. According to multivariate regression analysis, DM 2 was an independent factor associated with ICU admission (odds ratio 1.87, CI 1.14–3.06) and death (odds ratio 2.45, CI 1.35–4.45); p0.05. In patients with obesity and DM 2, CRP values of more than 107.8 and 125.7 mg/l have high prognostic value in relation to the risk of ICU admission and death. Conclusion. DM 2 is an independent factor in the severe course of COVID-19.